Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.
Earnings for Sequent Scientific Limited (SEQUENT.NS)
Earnings in 2023 (TTM): $-6,474,331
According to Sequent Scientific Limited's latest financial reports the company's current earnings (TTM) are $-6,474,331. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Sequent Scientific Limited
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-6,474,331 | $-4,249,676 |
| 2022 | $-16,309,519 | $-14,354,744 |
| 2021 | $6.33 M | $4.85 M |
| 2020 | $16.19 M | $11.31 M |
| 2019 | $11.15 M | $8.28 M |
| 2018 | $6.98 M | $5.77 M |
| 2017 | $2.8 M | $49.95 M |
| 2016 | $75.59 K | $-1,637,835 |
| 2015 | $-2,009,855 | $-2,624,991 |
| 2014 | $-7,501,888 | $-1,272,213 |
| 2013 | $-13,022,356 | $-13,090,954 |
| 2012 | $-8,619,251 | $-7,664,795 |
| 2011 | $-641,320 | $-165,750 |
| 2010 | $413.37 K | $-20,852 |
| 2009 | $4.68 M | $4.43 M |
| 2008 | $-1,497,676 | $-1,736,764 |
| 2007 | $439.33 K | $298.78 K |
| 2006 | $1.32 M | $1.02 M |